2,334
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Utilization of a nanostructured lipid carrier encapsulating pitavastatin–Pinus densiflora oil for enhancing cytotoxicity against the gingival carcinoma HGF-1 cell line

, , , , , , , , , & show all
Pages 83-96 | Received 06 Sep 2022, Accepted 28 Nov 2022, Published online: 12 Dec 2022

References

  • Abou-Taleb HA, Khallaf RA, Abdel-Aleem JA. (2018). Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation. Drug Des Devel Ther 12:3501–16.
  • Alhakamy NA, Hosny KM, Aldryhim AY, et al. (2022). Development and optimization of ofloxacin as solid lipid nanoparticles for enhancement of its ocular activity. J Drug Deliv Sci Technol 72:103373.
  • Arora S, Gupta S, Narang RK, Buthiraja RD. (2011). Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for H. Pylori. Sci Pharm 79:673–94.
  • Azhar Shekoufeh Bahari L, Hamishehkar H. (2016). The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature review. Adv Pharm Bull 6:143–51.
  • Barasch A, Morse DE, Krutchkoff DJ, Eisenberg E. (1994). Smoking, gender, and age as risk factors for site-specific intraoral squamous cell carcinoma. A case-series analysis. Cancer 73:509–13.
  • Bogman K, Peyer AK, Török M, et al. (2001). HMG-CoA reductase inhibitors and P-glycoprotein modulation. Br J Pharmacol 132:1183–92.
  • Casiglia J, Woo SB. (2001). A comprehensive review of oral cancer. Gen Dent 49:72–82.
  • Chauhan I, Yasir M, Verma M, Singh AP. (2020). Nanostructured lipid carriers: a groundbreaking approach for transdermal drug delivery. Adv Pharm Bull 10:150–65.
  • Corsini A, Bellosta S, Baetta R, et al. (1999). New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther 84:413–28.
  • Dantas MG, Reis SA, Damasceno CM, et al. (2016). Development and evaluation of stability of a gel formulation containing the monoterpene borneol. Sci World J 2016:7394685.
  • Decker T, Lohmann-Matthes ML. (1988). A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115:61–9.
  • Di Bello E, Zwergel C, Mai A, Valente S. (2020). The innovative potential of statins in cancer: new targets for new therapies. Front Chem 8:516.
  • Ee SL, Duan X, Liew J, Nguyen QD. (2008). Droplet size and stability of nanoemulsions produced by the temperature phase inversion method. Chem Eng J 140:626–31.
  • Elkomy MH, Khallaf RA, Mahmoud MO, et al. (2021). Intratracheally inhalable nifedipine-loaded chitosan-PLGA nanocomposites as a promising nanoplatform for lung targeting: snowballed protection via regulation of TGF-β/β-catenin pathway in bleomycin-induced pulmonary fibrosis. Pharmaceuticals (Basel) 14:1225.
  • El-Leithy ES, Shaker DS, Ghorab MK, Abdel-Rashid RS. (2010). Evaluation of mucoadhesive hydrogels loaded with diclofenac sodium-chitosan microspheres for rectal administration. AAPS PharmSciTech 11:1695–702.
  • Elmowafy M, Al-Sanea MM. (2021). Nanostructured lipid carriers (NLCs) as drug delivery platform: advances in formulation and delivery strategies. Saudi Pharm J 29:999–1012.
  • Elmowafy M, Ibrahim HM, Ahmed MA, et al. (2017). Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks. Drug Deliv 24:932–41.
  • Ferlay J, Soerjomataram I, Dikshit R, et al. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386.
  • Hoffman HT, Karnell LH, Funk GF, et al. (1998). The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 124:951–62.
  • Hosny KM, Rizg WY, Khallaf RA. (2020). Preparation and optimization of in situ gel loaded with rosuvastatin-ellagic acid nanotransfersomes to enhance the anti-proliferative activity. Pharmaceutics 12:263.
  • Hosny KM, Khallaf RA, Asfour HZ, et al. (2021). Development and optimization of cinnamon oil nanoemulgel for enhancement of solubility and evaluation of antibacterial, antifungal and analgesic effects against oral microbiota. Pharmaceutics 13:1008.
  • Hosny K, Asfour H, Rizg W, et al. (2021). Formulation, optimization, and evaluation of oregano oil nanoemulsions for the treatment of infections due to oral microbiota. Int J Nanomed 16:5–4655478.
  • Hosny KM, Sindi AM, Ali S, et al. (2022). Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis. Drug Deliv 29:254–62.
  • Hu FQ, Jiang SP, Du YZ, et al. (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B 45:167–73.
  • Hussein RM, Kandeil MA, Mohammed NA, Khallaf RA. (2022). Evaluation of the hepatoprotective effect of curcumin-loaded solid lipid nanoparticles against paracetamol overdose toxicity: Role of inducible nitric oxide synthase. J Liposome Res 8:1–11.
  • Ibrahim AB, Zaki HF, Ibrahim WW, et al. (2019). Evaluation of tamoxifen and simvastatin as the combination therapy for the treatment of hormonal dependent breast cancer cells. Toxicol Rep 6:1114–26.
  • Jain P, Rahi P, Pandey V, et al. (2017). Nanostructure lipid carriers: a modish contrivance to overcome the ultraviolet effects. Egypt J Basic Appl Sci 4:89–100.
  • Jaiswal P, Gidwani B, Vyas A. (2016). Nanostructured lipid carriers and their current application in targeted drug delivery. Artif Cells Nanomed Biotechnol 44:27–40.
  • Jenning V, Gohla SH. (2001). Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul 18:149–58.
  • Jo JR, Park JS, Park YK, et al. (2012). Pinus densiflora leaf essential oil induces apoptosis via ROS generation and activation of caspases in YD-8 human oral cancer cells. Int J Oncol 40:1238–45.
  • Kaja S, Payne AJ, Naumchuk Y, Koulen P. (2017). Quantification of lactate dehydrogenase for cell viability testing using cell lines and primary cultured astrocytes. Curr Protoc Toxicol 72:2.26.1–.26.10.
  • Kaur S, Nautyal U, Singh R, et al. (2015). Nanostructure lipid carrier (NLC): the new generation of lipid nanoparticles. Asian Pac J Health Sci 2:76–93.
  • Khallaf RA, Aboud HM, Sayed OM. (2020). Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation. J Liposome Res 30:163–73.
  • Kim KY, Chung HJ. (2000). Flavor compounds of pine sprout tea and pine needle tea. J Agric Food Chem 48:1269–72.
  • Kumar NS, Nirmal NN, Sonali J, Bagyalakshmi N. (2019). J. HPLC determination of pitavastatin calcium in pharmaceutical dosage forms. Pharm Anal Acta 2:119.
  • Leroux J, Allémann E, Doelker E, Gurny R. (1995). New approach for the preparation of nanoparticles by an emulsification-diffusion method. Eur J Pharm Biopharm 41:14–8.
  • Lippacher A, Müller RH, Mäder K. (2002). Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties. Eur J Pharm Biopharm 53:155–60.
  • López-García R, Ganem-Rondero A. (2015). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): occlusive effect and penetration enhancement ability. J Cosmet Dermatol Sci Appl 5:62–72.
  • Massano J, Regateiro FS, Januário G, Ferreira A. (2006). Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:67–76.
  • MÜhlen AZ, MÜhlen EZ, Niehus H, Mehnert W. (1996). Atomic force microscopy studies of solid lipid nanoparticles. Pharm Res 13:1411–16.
  • Muller RH. (2007). Lipid nanoparticles: recent advances. Adv Drug Del Rev 59:375–6.
  • Nakamura H, Arakawa K, Itakura H, et al. (2006). MEGA Study Group. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomized controlled trial. Lancet 368:1155–63.
  • Naseri N, Valizadeh H, Zakeri-Milani P. (2015). Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv Pharm Bull 5:305–13.
  • Nazar MR, Hafeezullah K, Shahzad N. (2010). Encapsulation and characterization of controlled release flurbiprofen loaded microspheres using beeswax as an encapsulating agent. J Mater Sci 21:1621–30.
  • Okazaki S, Yokoyama T, Miyauchi K, et al. (2004). Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study. Circulation 110:1061–8.
  • Patel JK, Patel RP, Amin AF, Patel MM. (2005). Formulation and evaluation of mucoadhesive glipizide microspheres. AAPS Pharm Sci Tech 6:49–55.
  • Persson LC, Porter CJ, Charman WN, Bergström CA. (2013). Computational prediction of drug solubility in lipid based formulation excipients. Pharm Res 30:3225–37.
  • Ramesh R, Sadasivan A. (2017). Oral squamous cell carcinoma masquerading as gingival overgrowth. Eur J Dent 11:390–4.
  • Rivera C. (2015). Essentials of oral cancer. Int J Clin Exp Pathol 8:11884–94.
  • Rizg WY, Hosny KM, Mahmoud SS, et al. (2022). Repurposing lovastatin cytotoxicity against the tongue carcinoma HSC3 cell line using a eucalyptus oil-based nanoemulgel carrier. Gels 8:176.
  • Saito Y. (2009). Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals. Vasc Health Risk Manag 5:921–36.
  • Saito Y. (2011). Pitavastatin: an overview. Atheroscler Suppl 12:271–6.
  • Salem HF, El-Menshawe SF, Khallaf RA, Rabea YK. (2020). A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension: optimization using Box–Benkhen design, in vitro and in vivo characterization. Drug Deliv Transl Res 10:227–40.
  • Salem HF, Nafady MM, Ewees MGE, et al. (2022). Rosuvastatin calcium-based novel nanocubic vesicles capped with silver nanoparticles-loaded hydrogel for wound healing management: optimization employing Box–Behnken design: in vitro and in vivo assessment. J Liposome Res 32:45–61.
  • Sarmento B, Ferreira D, Veiga F, Ribeiro A. (2006). Characterization of insulin loaded alginate nanoparticles produced by inotropic pre-gelation through DSC and FTIR studies. Carbohydr Polym 66:1–7.
  • Soo KC, Spiro RH, King W, et al. (1988). Squamous carcinoma of the gums. Am J Surg 156:281–5.
  • Szkaradkiewicz AK, Karpiński TM, Szkaradkiewicz A. (2014). Effect of novobiocin on the viability of human gingival fibroblasts (HGF-1). BMC Pharmacol Toxicol 15:25.
  • Tsubaki M, Fujiwara D, Takeda T, et al. (2017). The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways. Clin Exp Pharmacol Physiol 44:222–34.
  • Tsugeno Y, Sato F, Muragaki Y, Kato Y. (2014). Cell culture of human gingival fibroblasts, oral cancer cells and mesothelioma cells with serum-free media, STK1 and STK2. Biomed Rep 2:644–8.
  • Witayaudom P, Klinkesorn U. (2017). Effect of surfactant concentration and solidification temperature on the characteristics and stability of nanostructured lipid carrier (NLC) prepared from rambutan (Nephelium lappaceum L.) kernel fat. J Colloid Interface Sci 505:1082–92.
  • Xing H, Wang H, Wu B, et al. (2018). Lipid nanoparticles for the delivery of active natural medicines. Curr Pharm Des 23:6705–13.
  • Xu B, Muramatsu T, Inazawa J. (2021). Suppression of MET signaling mediated by pitavastatin and capmatinib inhibits oral and esophageal cancer cell growth. Mol Cancer Res 19:585–97.
  • Yang J, Choi WS, Jeung EB, et al. (2021). Anti-inflammatory effect of essential oil extracted from Pinus densiflora (Sieb. et Zucc.) wood on RBL-2H3 cells. J Wood Sci 67:52–64.
  • Yokomichi H, Nagai A, Hirata M, et al. (2017). Statin use and all-cause and cancer mortality: bioBank Japan cohort. J Epidemiol 27:S84–S91.